Statin therapy increased risk for 4 of 66 adverse outcomes listed in product labels compared with placebo at a median 4.5 y.
Where this comes from
- Record sourced from PubMed, PMID 42224694.
- Also identified by DOI 10.7326/ANNALS-26-01782-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text] Endocrinology: [Formula: see text] Public Health: [Formula: see text].
Medical subject headings
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Product Labeling